PRINCIPAL FINANCIAL GROUP INC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 128 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$29,000
-34.1%
10,811
+7.1%
0.00%
Q4 2021$44,000
-66.4%
10,099
-60.6%
0.00%
Q3 2021$131,000
+37.9%
25,601
+71.2%
0.00%
Q2 2021$95,000
-47.5%
14,956
-36.1%
0.00%
Q1 2021$181,000
+129.1%
23,399
+94.0%
0.00%
Q4 2020$79,000
-76.9%
12,063
-34.7%
0.00%
Q3 2018$342,000
-17.0%
18,480
+2.6%
0.00%
Q2 2018$412,00018,0100.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
BVF INC/IL 1,877,148$13,853,0001.46%
Congress Park Capital LLC 167,811$1,238,0001.04%
Perceptive Advisors 3,253,923$24,014,0000.65%
RTW INVESTMENTS, LP 990,463$7,310,0000.44%
Spark Investment Management LLC 337,164$2,488,0000.32%
Exane Asset Management 54,065$399,000,0000.31%
DAFNA Capital Management LLC 100,000$738,0000.28%
HARBOURVEST PARTNERS LLC 79,193$584,0000.24%
WELD CAPITAL MANAGEMENT LLC 86,363$637,0000.12%
GSA CAPITAL PARTNERS LLP 77,997$576,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders